 | Articles: Chemotherapy/Oncology |
Cell Killing and Resistance in Pre-Operative Breast Cancer Chemotherapy
BMC Clinical Pharmacology, 08/07/08
Phase I clinical and pharmacokinetic study of orally administered N 4-palmitoyl-1-beta-d -arabinofuranosylcytosine
Medical Oncology, 08/07/08
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)
European Journal of Cancer, 08/06/08
 | | Sponsor |
Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma
Medical Oncology, 08/06/08
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
Journal of Thoracic Oncology, 08/06/08
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
Journal of Thoracic Oncology, 08/06/08
Report of Eight Recent Cases of Locally Advanced Primary Pulmonary Artery Sarcomas: Failure of Doxorubicin-Based Chemotherapy
Journal of Thoracic Oncology, 08/06/08
Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy
The Laryngoscope, 08/05/08
A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel
Clinical Cancer Research, 08/05/08
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
Journal of Clinical Oncology, 08/05/08
|
 Receive daily email updates on Chemotherapy/Oncology
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
